Mao Sheng Duan

Corporate Officer/Principal en HD Biosciences Co., Ltd. .

Consumer Services

Health Services

Perfil

Mao Sheng Duan is currently the Vice President & Head-Medicinal Chemistry at HD Biosciences Co., Ltd.
Prior to this, he worked as the Chief Scientist at Glaxosmithkline China Ltd.
Dr. Duan received his doctorate degree from The Ohio State University and his undergraduate and graduate degrees from Central China Normal University and Nankai University respectively.

Cargos activos de Mao Sheng Duan

Empresas	Cargo	Inicio
HD Biosciences Co., Ltd. HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China.	Corporate Officer/Principal	-

Todos los cargos activos de Mao Sheng Duan

Antiguos cargos conocidos de Mao Sheng Duan.

Empresas	Cargo	Fin
Glaxosmithkline China Ltd.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Mao Sheng Duan.

Formación de Mao Sheng Duan.

Central China Normal University	Undergraduate Degree
Nankai University	Graduate Degree
The Ohio State University	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mao Sheng Duan.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
HD Biosciences Co., Ltd. HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China.	Health Services
Glaxosmithkline China Ltd.